MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/03/6405-1092-1100$20.00
Mol Pharmacol 64:1092-1100, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Onoprishvili, I.
Right arrow Articles by Simon, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Onoprishvili, I.
Right arrow Articles by Simon, E. J.

Interaction Between the µ Opioid Receptor and Filamin A Is Involved in Receptor Regulation and Trafficking

Irma Onoprishvili, Matthew L. Andria, Hal K. Kramer, Natasa Ancevska-Taneva, Jacob M. Hiller, and Eric J. Simon

Departments of Psychiatry (I.O., M.L.A., H.K.K., N.A-T., J.M.H., E.J.S.) and Pharmacology (E.J.S.), New York University School of Medicine, New York, New York

The carboxyl tail of the human µ opioid receptor was shown to bind the carboxyl terminal region of human filamin A, a protein known to couple membrane proteins to actin. Results from yeast two-hybrid screening were confirmed by direct protein-protein binding and by coimmunoprecipitation of filamin and µ opioid receptor from cell lysates. To investigate the role of filamin A in opioid receptor function and regulation, we used the melanoma cell line M2, which does not express filamin A, and its subclone A7, transfected with human filamin A cDNA. Both cell lines were stably transfected with cDNA encoding myc-tagged human µ opioid receptor. Fluorescent studies, using confocal microscopy, provided evidence that filamin and µ opioid receptors were extensively colocalized on the membranes of filamin-expressing melanoma cells. The immunostaining of µ opioid receptors indicated that the lack of filamin had no detectable effect on membrane localization of the receptors. Moreover, µ opioid receptors function normally in the absence of filamin A, as evidenced by studies of opioid binding and DAMGO inhibition of forskolin-stimulated adenylyl cyclase. However, agonist-induced receptor down-regulation and functional desensitization were virtually abolished in cells lacking filamin A. The level of internalized µ-opioid receptors, after 30-min exposure to agonist, was greatly reduced, suggesting a role for filamin in µ opioid receptor trafficking. During these studies, we observed that forskolin activation of adenylyl cyclase was greatly reduced in filamin-lacking cells. An even more unexpected finding was the ability of long-term treatment with [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin of M2 cells, containing µ opioid receptors, to restore normal forskolin activation. The mechanism of this effect is currently unknown. It is postulated that the observed effects on µ opioid receptor regulation by filamin A and, by implication, of the actin cytoskeleton may be the result of its role in µ opioid receptor trafficking.


Address correspondence to: Dr. Eric J. Simon, Department of Psychiatry, 550 First Ave., New York, NY 10016. E-mail: eric.simon{at}nyu.edu




This article has been cited by other articles:


Home page
EndocrinologyHome page
J. L. Fiori, T.-N. Zhu, M. P. O'Connell, K. S. Hoek, F. E. Indig, B. P. Frank, C. Morris, S. Kole, J. Hasskamp, G. Elias, et al.
Filamin A Modulates Kinase Activation and Intracellular Trafficking of Epidermal Growth Factor Receptors in Human Melanoma Cells
Endocrinology, June 1, 2009; 150(6): 2551 - 2560.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Beekman, C. E. van der Poel, J. A. van der Linden, D. L. C. van den Berg, P. V. E. van den Berghe, J. G. J. van de Winkel, and J. H. W. Leusen
Filamin A Stabilizes Fc{gamma}RI Surface Expression and Prevents Its Lysosomal Routing
J. Immunol., March 15, 2008; 180(6): 3938 - 3945.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
E.-Y. Cho, D.-I. Cho, J. H. Park, H. Kurose, M. G. Caron, and K.-M. Kim
Roles of Protein Kinase C and Actin-Binding Protein 280 in the Regulation of Intracellular Trafficking of Dopamine D3 Receptor
Mol. Endocrinol., September 1, 2007; 21(9): 2242 - 2254.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Y. Kim, L. D. Ridgway, and S. E. Dryer
Interactions with Filamin A Stimulate Surface Expression of Large-Conductance Ca2+-Activated K+ Channels in the Absence of Direct Actin Binding
Mol. Pharmacol., September 1, 2007; 72(3): 622 - 630.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D.-F. Wu, T. Koch, Y.-J. Liang, R. Stumm, S. Schulz, H. Schroder, and V. Hollt
Membrane Glycoprotein M6a Interacts with the {micro}-Opioid Receptor and Facilitates Receptor Endocytosis and Recycling
J. Biol. Chem., July 27, 2007; 282(30): 22239 - 22247.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
A. M. Daulat, P. Maurice, C. Froment, J.-L. Guillaume, C. Broussard, B. Monsarrat, P. Delagrange, and R. Jockers
Purification and Identification of G Protein-coupled Receptor Protein Complexes under Native Conditions
Mol. Cell. Proteomics, May 1, 2007; 6(5): 835 - 844.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Cabello, R. Remelli, L. Canela, A. Soriguera, J. Mallol, E. I. Canela, M. J. Robbins, C. Lluis, R. Franco, R. A. J. McIlhinney, et al.
Actin-binding Protein {alpha}-Actinin-1 Interacts with the Metabotropic Glutamate Receptor Type 5b and Modulates the Cell Surface Expression and Function of the Receptor
J. Biol. Chem., April 20, 2007; 282(16): 12143 - 12153.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
D. Liao, O. O. Grigoriants, H. H. Loh, and P.-Y. Law
Agonist-Dependent Postsynaptic Effects of Opioids on Miniature Excitatory Postsynaptic Currents in Cultured Hippocampal Neurons
J Neurophysiol, February 1, 2007; 97(2): 1485 - 1494.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y.-J. Liang, D.-F. Wu, L.-Q. Yang, V. Hollt, and T. Koch
Interaction of the {micro}-Opioid Receptor with Synaptophysin Influences Receptor Trafficking and Signaling
Mol. Pharmacol., January 1, 2007; 71(1): 123 - 131.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. G. H. Scott, V. Pierotti, H. Storez, E. Lindberg, A. Thuret, O. Muntaner, C. Labbe-Jullie, J. A. Pitcher, and S. Marullo
Cooperative Regulation of Extracellular Signal-Regulated Kinase Activation and Cell Shape Change by Filamin A and {beta}-Arrestins.
Mol. Cell. Biol., May 1, 2006; 26(9): 3432 - 3445.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. N. Talbot, H. K. Happe, and L. C. Murrin
{micro} Opioid Receptor Coupling to Gi/o Proteins Increases during Postnatal Development in Rat Brain
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 596 - 602.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K.-M. Kim, R. R. Gainetdinov, S. A. Laporte, M. G. Caron, and L. S. Barak
G Protein-coupled Receptor Kinase Regulates Dopamine D3 Receptor Signaling by Modulating the Stability of a Receptor-Filamin-{beta}-Arrestin Complex: A CASE OF AUTORECEPTOR REGULATION
J. Biol. Chem., April 1, 2005; 280(13): 12774 - 12780.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Zhang and G. E. Breitwieser
High Affinity Interaction with Filamin A Protects against Calcium-sensing Receptor Degradation
J. Biol. Chem., March 25, 2005; 280(12): 11140 - 11146.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics